We are monitoring the impact of COVID-19 on Next-Generation Sequencing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 92
Share on
Share on

Global Next-Generation Sequencing Market Size, Share, Trends, Growth, COVID-19 Impact Analysis Report - Segmented By Product, Technology, Application and Region - Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 92
Pages: 175

Next-Generation Sequencing Market Size (2021 to 2026)

As per this report, the Market Data Forecast says, the global NGS market size is estimated to grow USD 10.13 billion by 2026 from USD 4.31 billion in 2021, growing at a CAGR of 18.66% during the forecast period.

The next-generation sequencing (NGS) approach uses massively parallel processing in the formation of DNA sequencing. There are two methods to prepare the templates, namely amplified templates originated from single molecules and single DNA molecule templates. NGS plays a pivotal role in clinical practice by improving diagnosis procedures. This technique is mainly used in discovering disease-causing genes. It takes a single day to complete the entire human genome with this technique.

MARKET DRIVERS:

Increasing incidences of chronic diseases are undoubtedly a significant factor propelling global next-generation sequencing market growth.

Growing investments in the research institutes in the biotechnology field are accelerating the growth of the market. The rise in the need to improve diagnostic procedures and also to ensure quality treatment is propelling the development of this market.

Growing studies on genomes are likely to outshine the demand of the global NGS market.

Increasing the geriatric population is also a common factor leveling up the growth rate of this next-generation sequencing market. Growth opportunities for the lie in the government's rising support in introducing reimbursement schemes in favor of the public.

Next-generation sequences will provide enormous cloud computing opportunities as potential data management services in the emerging markets offer numerous opportunities to the companies operating in this space. Opportunities will be delivered due to growth in the government initiatives for the genomics projects in large-scale industries like drug developments and research of the clinical diagnostics processes. Nowadays, the growing trend in medicine of personalized medical facilities in the next-generation sequencing market.

MARKET RESTRAINTS:

The cost of installation and maintenance of the equipment in laboratories is a bit expensive, which is slowly impeding the market's growth.

Lack of standardization is also an attribute limiting the demand of the NGS market. The major challenge faced by the next-generation sequencing market is the interpretation of the data's DNA sequence, acceleration of the analysis of the data, shortage in the storage of the data generated in the bottleneck. There are serious issues like data originating from the diverse datasets usage, which needs to be addressed. Poor in records of the data sequences. Some DNA’s like short fragments should be analyzed and compared with the reference databases, which is against but efficient and fast. To face these many challenges, many solutions were proposed by the commercial software and industries, but still existing many hardships to handle.

Another significant challenge is updating the data to the central or disturbed data storage and analysis services by the clients' computers and the data parallelization using the grid or cloud solutions.

Impact of COVID-19 on the global NGS market:

Next-generation sequences have a crucial and essential role in the clinical labs and research to fight against the SARScov-2, which results in the COVID-19. When the world is fighting against the dangerous disease that is the COVD-19 pandemic, there is an evolution in the genome, giving vital insights on spreading the impact on different people. To fight against the COVID-19, the researchers are, and scientists together found information by the next generation sequence. Flomics are the latest research findings active in monitoring and contributing to the specialty in the following generation sequencing field. It helps find the cruciality of the interaction between the viral and host genomes, which helps find the individuals levels of riskiness.

The next-generation sequence gives an idea with a deep understanding of the disease and the impact of the pandemic on humans' health. The biotech partners, which are national and international, joined the force by Flomics with the specialization of the NGS tests, which helps develop the solutions based on the cloud to detect the COVID-19. Transformation of the raw data into interpretable clinical information will help manage the pandemic without bioinformatics expertise but within a few clicks from any place like clinics, hospitals, and research laboratories. 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Product, Technology, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

 

This research report on the global next-generation sequencing market has been segmented and sub-segmented based on the product, technology, application, and region.

Next-Generation Sequencing Market - By Product:

  • Software
  • Services

Based on the product, the services segment is leading with the highest shares of the market. The rise in the number of genetic disorders across the world is fuelling the demand for this segment. Additionally, the increase in the demand for sequence-based products, the need for data management services on storing a large amount of data, adopting the genetic test within a short period, existing guidelines, and health reimbursement policies further help the segment to occupy the leading position.

Next-Generation Sequencing Market - By Technology:

  • Targeted Re-Sequencing
  • Whole Genome Sequencing
  • De Novo Sequencing
  • Exome Sequencing
  • RNA-Seq
  • ChIP-Seq
  • Methyl-Seq

Among the mentioned applications, Targeted sequencing is expected to show the highest growth during the forecast period due to the growing capabilities for whole-genome sequencing. The whole Genome sequencing segment is projected to showcase a healthy growth rate over the forthcoming years.

Next-Generation Sequencing Market - By Application:

  • Diagnostics
  • Drug Discovery
  • Biomarker Discovery
  • Personalized Medicine
  • Agriculture and Animals Research

Based on the application, the diagnostics segment is accounted for the largest share in the NGS market in 2020 and estimated to happen the same throughout the forecast period. With a growing number of cancer cases worldwide, reimbursement policies from the government that are favorable towards NGS-based tests in the U.S. are majorly anticipating the growth of this segment.

Personalized medicine segment to have an attractive growth rate during the forecast period. Increasing awareness related to NGS, growing demand for independent drug treatment, and early detection or prevention of disorders are likely to enhance the segment growth during the analysis period.

Next-Generation Sequencing Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the North American regional market is poised to account for the prime market share in the global NGS market, followed by Europe. Due to increased technological innovations and growing investments in the field, North America is expected to register the highest CAGR and dominate the market during the forecast period. Market growth is driven by the advancement of NGS bioinformatics solutions and significant players in the region.

China is expected to grow at the highest CAGR showing with Y-O-Y Growth Rate between 20.3% to 30.6% range from 2019 to 2024. The presence of noteworthy developments in China and Japan to integrate new technologies and the development of healthcare, R&D, and clinical development frameworks of developing economies such as India and Australia have led the Asia Pacific market to witness rewarding growth throughout the forecast period.

KEY COMPANIES IN THE NGS MARKET:

Noteworthy Companies leading the global next-generation sequencing market profiled in the report are IlluminaThermo Fisher ScientificPacific Biosciences, Macrogen Inc., Partek Inc.Genomatix Software GmbH, Perkin Elmer Inc., GATC Biotech Ag, Agilent Technologies Inc., Biomatters Ltd., BGI (Beijing Genomics Institute), Oxford Nanopore Technologies Ltd., DNASTAR Inc., Knome Inc., and Qiagen N.V.

KEY RECENT DEVELOPMENTS IN THE NGS MARKET:

  • In July 2020, Illumina introduced software for whole-genome analysis to examine rare diseases. This software is helped in making it comfortable in identifying the genetic elements behind the rare diseases.
  • In July 2019, DNASTAR launched Lasergene16, which involves a wide range of improvements for analyzing DNA or RNA and protein sequence data and advancements in analyzing protein structures.
  • In July 2020, Thermo Fisher Scientific made a strategic partnership with First Genetics JCS, concentrating on promoting NGS-based diagnostics assays in Russia. This agreement allows the market for reproductive health testing and cancer diagnostics. 
  • In April 2019, food and drug administration guidelines were released to design, develop, and validate the NGS tests. These guidelines help companies detect specific variants in a clinical setting with high accuracy and support innovative tools in the NGS-based tests.

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Analysis Design         

                2.3 Research Phases      

                                2.3.1 Secondary Research

                                2.3.2 Primary Research

                                2.3.3 Econometric Modelling

                                2.3.4 Expert Validation

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 By Product  

                                5.1.1 Software

                                5.1.2 Services

                5.2 By Technology          

                                5.2.1 Whole Targeted Re-Sequencing

                                5.2.2 Genome Sequencing

                                5.2.3 De Novo Sequencing

                                5.2.4 Exome Sequencing

                                5.2.5 RNA-Seq

                                5.2.6 ChIP-Seq

                                5.2.7 Methyl-Seq

                5.3 By Application           

                                5.3.1 Diagnostics

                                5.3.2 Drug Discovery

                                5.3.3 Biomarker Discovery

                                5.3.4 Personalized Medicine

                                5.3.5 Agriculture and Animals Research

6. Geographical Analysis                              

                6.1 North America          

                                6.1.1 Introduction

                                6.1.2 United States

                                6.1.3 Canada 

                6.2 Europe         

                                6.2.1 Introduction

                                6.2.2 U.K

                                6.2.3 Spain

                                6.2.4 Germany

                                6.2.5 Italy 

                                6.2.6 France

                6.3 Asia-Pacific 

                                6.3.1 Introduction

                                6.3.2 China 

                                6.3.3 India 

                                6.3.4 Japan 

                                6.3.5 South Korea

                6.4 Latin America            

                                6.4.1 Introduction

                                6.4.2 Brazil

                                6.4.3 Argentina

                                6.4.4 Mexico

                                6.4.5 Rest of Latin America

                6.5 Middle East & Africa

                                6.5.1 Introduction

                                6.5.2 Middle East

                                6.5.3 Africa

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Illumina Inc.          

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Financial analysis

                                8.1.4 Recent Developments 

                                8.1.5 SWOT analysis

                                8.1.6 Analyst View

                8.2 Thermo Fisher Scientific  

                8.3 Life Sciences (Roche)             

                8.4 Pacific Biosciences  

                8.5 Macrogen Inc.       

                8.6 Partek Inc.  

                8.7 Genomatix Software GmbH

                8.8 Perkin Elmer inc.      

                8.9 GATC Biotech Ag      

                8.10 Agilent Technologies Inc.   

                8.11 Biomatters Ltd.      

                8.12 CLC Bio (Qiagen)    

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Expert Opinions                         

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global NGS Market, By Region, From 2021 to 2026 (USD Billion)
  2. Global NGS Market, By Product, From 2021 to 2026 (USD Billion)
  3. Global Software Market, By Region, From 2021 to 2026 (USD Billion)
  4. Global Services Market, By Region, From 2021 to 2026 (USD Billion)
  5. Global NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  6. Global Whole Targeted Re-Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  7. Global Genome Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  8. Global De Novo Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  9. Global Exome Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  10. Global RNA-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  11. Global ChIP-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  12. Global Methyl-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  13. Global NGS Market, By Application, From 2021 to 2026 (USD Billion)
  14. Global Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  15. Global Drug Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  16. Global Biomarker Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  17. Global Personalized Medicine Market, By Region, From 2021 to 2026 (USD Billion)
  18. Global Agriculture and Animals Research Market, By Region, From 2021 to 2026 (USD Billion)
  19. North America NGS Market, By Region, From 2021 to 2026 (USD Billion)
  20. North America NGS Market, By Product, From 2021 to 2026 (USD Billion)
  21. North America Software Market, By Region, From 2021 to 2026 (USD Billion)
  22. North America Services Market, By Region, From 2021 to 2026 (USD Billion)
  23. North America NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  24. North America Whole Targeted Re-Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  25. North America Genome Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  26. North America De Novo Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  27. North America Exome Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  28. North America RNA-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  29. North America ChIP-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  30. North America Methyl-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  31. North America NGS Market, By Application, From 2021 to 2026 (USD Billion)
  32. North America Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  33. North America Drug Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  34. North America Biomarker Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  35. North America Personalized Medicine Market, By Region, From 2021 to 2026 (USD Billion)
  36. North America Agriculture and Animals Research Market, By Region, From 2021 to 2026 (USD Billion)
  37. United States NGS Market, By Product, From 2021 to 2026 (USD Billion)
  38. United States NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  39. United States NGS Market, By Application, From 2021 to 2026 (USD Billion)
  40. Canada NGS Market, By Product, From 2021 to 2026 (USD Billion)
  41. Canada NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  42. Canada NGS Market, By Application, From 2021 to 2026 (USD Billion)
  43. Europe NGS Market, By Region, From 2021 to 2026 (USD Billion)
  44. Europe NGS Market, By Product, From 2021 to 2026 (USD Billion)
  45. Europe Software Market, By Region, From 2021 to 2026 (USD Billion)
  46. Europe Services Market, By Region, From 2021 to 2026 (USD Billion)
  47. Europe NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  48. Europe Whole Targeted Re-Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  49. Europe Genome Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  50. Europe De Novo Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  51. Europe Exome Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  52. Europe RNA-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  53. Europe ChIP-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  54. Europe Methyl-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  55. Europe NGS Market, By Application, From 2021 to 2026 (USD Billion)
  56. Europe Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  57. Europe Drug Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  58. Europe Biomarker Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  59. Europe Personalized Medicine Market, By Region, From 2021 to 2026 (USD Billion)
  60. Europe Agriculture and Animals Research Market, By Region, From 2021 to 2026 (USD Billion)
  61. U.K. NGS Market, By Product, From 2021 to 2026 (USD Billion)
  62. U.K. NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  63. U.K. NGS Market, By Application, From 2021 to 2026 (USD Billion)
  64. Germany NGS Market, By Product, From 2021 to 2026 (USD Billion)
  65. Germany NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  66. Germany NGS Market, By Application, From 2021 to 2026 (USD Billion)
  67. France NGS Market, By Product, From 2021 to 2026 (USD Billion)
  68. France NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  69. France NGS Market, By Application, From 2021 to 2026 (USD Billion)
  70. Italy NGS Market, By Product, From 2021 to 2026 (USD Billion)
  71. Italy NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  72. Italy NGS Market, By Application, From 2021 to 2026 (USD Billion)
  73. Spain NGS Market, By Product, From 2021 to 2026 (USD Billion)
  74. Spain NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  75. Spain NGS Market, By Application, From 2021 to 2026 (USD Billion)
  76. Asia-Pacific NGS Market, By Region, From 2021 to 2026 (USD Billion)
  77. Asia-Pacific NGS Market, By Product, From 2021 to 2026 (USD Billion)
  78. Asia-Pacific Software Market, By Region, From 2021 to 2026 (USD Billion)
  79. Asia-Pacific Services Market, By Region, From 2021 to 2026 (USD Billion)
  80. Asia-Pacific NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  81. Asia-Pacific Whole Targeted Re-Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  82. Asia-Pacific Genome Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  83. Asia-Pacific De Novo Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  84. Asia-Pacific Exome Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  85. Asia-Pacific RNA-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  86. Asia-Pacific ChIP-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  87. Asia-Pacific Methyl-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  88. Asia-Pacific NGS Market, By Application, From 2021 to 2026 (USD Billion)
  89. Asia-Pacific Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  90. Asia-Pacific Drug Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  91. Asia-Pacific Biomarker Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  92. Asia-Pacific Personalized Medicine Market, By Region, From 2021 to 2026 (USD Billion)
  93. Asia-Pacific Agriculture and Animals Research Market, By Region, From 2021 to 2026 (USD Billion)
  94. China NGS Market, By Product, From 2021 to 2026 (USD Billion)
  95. China NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  96. China NGS Market, By Application, From 2021 to 2026 (USD Billion)
  97. India NGS Market, By Product, From 2021 to 2026 (USD Billion)
  98. India NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  99. India NGS Market, By Application, From 2021 to 2026 (USD Billion)
  100. Japan NGS Market, By Product, From 2021 to 2026 (USD Billion)
  101. Japan NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  102. Japan NGS Market, By Application, From 2021 to 2026 (USD Billion)
  103. South Korea NGS Market, By Product, From 2021 to 2026 (USD Billion)
  104. South Korea NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  105. South Korea NGS Market, By Application, From 2021 to 2026 (USD Billion)
  106. Latin America NGS Market, By Region, From 2021 to 2026 (USD Billion)
  107. Latin America NGS Market, By Product, From 2021 to 2026 (USD Billion)
  108. Latin America Software Market, By Region, From 2021 to 2026 (USD Billion)
  109. Latin America Services Market, By Region, From 2021 to 2026 (USD Billion)
  110. Latin America NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  111. Latin America Whole Targeted Re-Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  112. Latin America Genome Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  113. Latin America De Novo Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  114. Latin America Exome Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  115. Latin America RNA-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  116. Latin America ChIP-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  117. Latin America Methyl-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  118. Latin America NGS Market, By Application, From 2021 to 2026 (USD Billion)
  119. Latin America Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  120. Latin America Drug Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  121. Latin America Biomarker Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  122. Latin America Personalized Medicine Market, By Region, From 2021 to 2026 (USD Billion)
  123. Latin America Agriculture and Animals Research Market, By Region, From 2021 to 2026 (USD Billion)
  124. Brazil NGS Market, By Product, From 2021 to 2026 (USD Billion)
  125. Brazil NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  126. Brazil NGS Market, By Application, From 2021 to 2026 (USD Billion)
  127. Argentina NGS Market, By Product, From 2021 to 2026 (USD Billion)
  128. Argentina NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  129. Argentina NGS Market, By Application, From 2021 to 2026 (USD Billion)
  130. Mexico NGS Market, By Product, From 2021 to 2026 (USD Billion)
  131. Mexico NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  132. Mexico NGS Market, By Application, From 2021 to 2026 (USD Billion)
  133. Rest of Latin America NGS Market, By Product, From 2021 to 2026 (USD Billion)
  134. Rest of Latin America NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  135. Rest of Latin America NGS Market, By Application, From 2021 to 2026 (USD Billion)
  136. Middle East & Africa NGS Market, By Region, From 2021 to 2026 (USD Billion)
  137. Middle East & Africa NGS Market, By Product, From 2021 to 2026 (USD Billion)
  138. Middle East & Africa Software Market, By Region, From 2021 to 2026 (USD Billion)
  139. Middle East & Africa Services Market, By Region, From 2021 to 2026 (USD Billion)
  140. Middle East & Africa NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  141. Middle East & Africa Whole Targeted Re-Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  142. Middle East & Africa Genome Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  143. Middle East & Africa De Novo Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  144. Middle East & Africa Exome Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  145. Middle East & Africa RNA-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  146. Middle East & Africa ChIP-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  147. Middle East & Africa Methyl-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  148. Middle East & Africa NGS Market, By Application, From 2021 to 2026 (USD Billion)
  149. Middle East & Africa Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  150. Middle East & Africa Drug Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  151. Middle East & Africa Biomarker Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  152. Middle East & Africa Personalized Medicine Market, By Region, From 2021 to 2026 (USD Billion)
  153. Middle East & Africa Agriculture and Animals Research Market, By Region, From 2021 to 2026 (USD Billion)
  154. Middle East NGS Market, By Product, From 2021 to 2026 (USD Billion)
  155. Middle East NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  156. Middle East NGS Market, By Application, From 2021 to 2026 (USD Billion)
  157. Africa NGS Market, By Product, From 2021 to 2026 (USD Billion)
  158. Africa NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  159. Africa NGS Market, By Application, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample